ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Immunoglobulin light chain (AL) amyloidosis

Society guideline links: Immunoglobulin light chain (AL) amyloidosis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Monoclonal gammopathy of undetermined significance" and "Society guideline links: Multiple myeloma".)

International

European Hematology Association (EHA)-International Society of Amyloidosis (ISA): Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis (2022)

EHA-ISA: Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis (2021)

International Myeloma Working Group (IMWG): Criteria for the diagnosis of multiple myeloma, update (2014)

IMWG: Guidelines for serum-free light chain analysis in multiple myeloma and related disorders (2009)

Canada

Myeloma Canada Research Network (MCRN): Consensus guidelines on the diagnosis of multiple myeloma and related disorders (2020)

Cancer Care Ontario (CCO): Recommendation report on stem cell transplantation in primary systemic amyloidosis (2019)

Europe

European Hematology Association (EHA)-International Society of Amyloidosis (ISA): Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis (2022)

EHA-ISA: Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis (2021)

European Myeloma Network (EMN): Recommendations on diagnosis and management of patients with rare plasma cell dyscrasias (2018)

United Kingdom

British Society of Haematology (BSH): Guidelines on the diagnosis and investigation of AL amyloidosis (2015)

BSH: Guidelines on the management of AL amyloidosis (2015)

Australia-New Zealand

Medical Scientific Advisory Group to the Myeloma Foundation of Australia (MSAG MFA): Clinical practice guideline on the management of systemic AL amyloidosis (2015)

Japan

[In Japanese] Japanese Society of Hematology (JSH): Hematopoietic tumor clinical practice guidelines, 2nd edition (2018, revised 2020)

Topic 119668 Version 9.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟